kallisio,inc.

medical devices

About

Kallisio delivers patient-specific medtech solutions that help oncologists reduce treatment-related toxicity and protect healthy tissue in cancer care. By developing customized technologies tailored to each patient's anatomy and treatment plan, Kallisio enhances therapy precision and improves outcomes across multiple treatment modalities. The stentra™ oral stent, an FDA approved 3D-printed patient-specific device, exemplifies this approach. It provides unparalleled protection for Organs-at-Risk (OARs) during head and neck cancer therapy, significantly reducing side effects like oral mucositis. This results in better patient outcomes, enhanced comfort, and improved quality of life during treatment. Through our commitment to precision, innovation, and patient-centered care, Kallisio transforms oncology treatment, enabling clinicians to deliver safer, more effective therapies while reducing the burden of cancer toxicity.

Technologies

Gmail Google Apps reCAPTCHA Google Font API Google Tag Manager Varnish Mobile Friendly WordPress.org Wix

Keywords

head neck cancer radiation therapy immobilization 3d printed devices patientspecific toxicity management device as a service mucositis oncology medtech medical equipment manufacturing 3d printing personalized radiotherapy support workflow automation data-driven treatment support innovative head and neck cancer therapies seamless clinical integration medical devices automated design software tongue displacement device medical equipment and supplies manufacturing patient-specific intraoral stent clinical validation medical-grade biocompatible materials fda-cleared medical devices digital health platform 3d-printed medical devices b2b medical device compliance

Location

1734 Maryland Ave, Baltimore, Maryland, United States, 21201-5804

Related Companies

Companies in the same industry